Literature DB >> 32732277

Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 32732277     DOI： 10.1136/bmj.m3049

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Validation of a manual of care plans for people hospitalized with COVID-19.

Authors:  Alexandra González Aguña; Marta Fernández Batalla; Javier Díaz-Tendero Rodríguez; Juan Antonio Sarrión Bravo; Blanca Gonzalo de Diego; José María Santamaría García
Journal:  Nurs Open       Date:  2021-05-06

2.  Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19.

Authors:  Tianchuan Zhu; Yuchen Xiao; Xiaojun Meng; Lantian Tang; Bin Li; Zhaoyan Zhao; Qingqin Tan; Hong Shan; Lei Liu; Xi Huang
Journal:  J Nanobiotechnology       Date:  2021-11-25       Impact factor: 10.435

Review 3.  COVID-19: Myths and Reality.

Authors:  Larisa V Kordyukova; Andrey V Shanko
Journal:  Biochemistry (Mosc)       Date:  2021-07       Impact factor: 2.487

Review 4.  Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review.

Authors:  Juan Pimentel; Cassandra Laurie; Anne Cockcroft; Neil Andersson
Journal:  Br J Clin Pharmacol       Date:  2020-12-15       Impact factor: 3.716
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.